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Abstract 
This study examined whether expectancy of ergogenicity of a commonly 
used nutritional supplement (sodium bicarbonate; NaHCO3) influenced 
subsequent high-intensity cycling capacity. Eight recreationally active males 
(age: 21±1 years, body mass: 75±8 kg, height: 178±4 cm, WPEAK: 204±23 W) 
performed a graded incremental test to assess peak power output (WPEAK), 
one familiarisation trial and two experimental trials. Experimental trials 
consisted of cycling at 100% WPEAK to volitional exhaustion (TLIM) 60 min after 
ingesting either a placebo (PLA; 0.1 g.kg-1 sodium chloride (NaCl), 4 ml.kg-1 
tap water and 1 ml.kg-1 squash) or a sham placebo (SHAM; 0.1 g.kg-1 NaCl, 
4 ml.kg-1 carbonated water and 1 ml.kg-1 squash). SHAM aimed to replicate 
the previously reported symptoms of gut fullness (GF) and abdominal 
discomfort (AD) associated with NaHCO3 ingestion. Treatments were 
administered double blind and accompanied by written scripts designed to 
remain neutral (PLA) or induce expectancy of ergogenicity (SHAM). After 
SHAM mean TLIM increased by 9.5% compared to PLA (461±148 s vs. 
421±150 s; P=0.048, d=0.3). Ratings of GF and AD were mild but ~ 1 unit 
higher post ingestion for SHAM. After 3 min TLIM RPEO was 1.4±1.3 units 
lower for SHAM compared to PLA (P=0.020, d=0.6). There were no 
differences between treatments for blood lactate, blood glucose or heart rate. 
In summary, ergogenicity after NaHCO3 ingestion might be influenced by 
expectancy which mediates perception of effort during subsequent exercise. 
The observed ergogenicity with SHAM did not affect our measures of 
cardiorespiratory physiology or metabolic flux. 
Keywords: Psychobiology, endurance, fatigue, RPE, perceived exertion 
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Introduction 
 
A significant amount of research has examined the efficacy of sodium 
bicarbonate (NaHCO3) as an ergogenic aid (Cameron et al. 2010; Krustrup 
et al. 2015; Lavender and Bird 1989; Price and Simons 2010; Tan, et al. 
2010). Cameron et al. (2010) reported that ingestion of 0.3 g.kg-1 NaHCO3 60 
min prior to exercise had no effect on multiple indices of repeated sprint 
performance in elite rugby players. Cameron et al. (2010) suggested the 
most likely reason for the lack of performance enhancement was due to the 
higher frequency and greater severity of gastrointestinal (GI) symptoms after 
NaHCO3 ingestion. However, the lack of performance improvement might 
also have been influenced by the trained nature of participants with Peart et 
al. (2012) reporting that untrained individuals are significantly more likely to 
experience ergogenic benefit with NaHCO3. Indeed it is now well established 
that individuals who undertake high-intensity training have elevated levels of 
muscle carnosine compared with endurance trained and untrained 
individuals (Parkhouse and McKenzie 1984; Parkhouse et al. 1985). As 
carnosine is thought to play an important role in the homeostasis of muscle 
cells during high-intensity exercise (as an intracellular buffer) greater basal 
levels might ‘offset’ any potential ergogenic contribution from augmented 
extracellular NaHCO3 (Aschenbach et al. 2000; Derave et al. 2010). 
 
In support of this, Higgins et al. (2013) reported that recreationally 
active healthy males who ingested 0.3 g.kg-1 NaHCO3 60 min prior to cycling 
at 100% WPEAK to volitional exhaustion (TLIM) had on average 17% greater 
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exercise capacity versus a taste matched placebo. Furthermore, the 
individual who had the highest increase in TLIM (+38%) also reported 
moderate-high GI symptoms 30 min prior and immediately prior to exercise. 
The authors suggested that GI symptoms might not necessarily negatively 
affect exercise performance, something that is supported by previous 
research (Price and Simons 2010).   
 
According to Clark et al. (2000; pg 1642), the placebo effect is “...a 
favourable outcome arising purely from belief that one has received a 
beneficial treatment...” Expectancy is closely associated and in some 
instances assumed to have a direct relationship with the placebo effect 
(Kirsch 1985). It is suggested by enhancing the degree of expectancy, 
subsequently ones belief in the effectiveness of the placebo might increase 
(Evans 2003). The effects of expectancy on sport and exercise performance 
has been evaluated in a variety of different experimental models (Broatch et 
al. 2014; Maganaris et al. 2000; McClung and Collins 2007; Ross et al. 
2015). For example, Maganaris et al., (2000) administered a saccharine 
placebo to eleven national level power lifters but provided false information to 
enhance expectancy of performance benefit. Participants were led to believe 
that they had consumed anabolic steroids which resulted in changes from 
baseline of 10±2 kg, 11±2 kg and 12±1 kg, for maximal bench press, dead lift 
and squat performance, respectively. However, when approximately half of 
the group were told the true nature of the placebo these performance gains 
almost completely dissipated although remained for the group who believed 
they had consumed anabolic steroids (Maganaris, et al. 2000). 
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To the best of our knowledge, only one study has previously 
evaluated the effects of expectancy on exercise performance with respect of 
NaHCO3 ingestion (McClung and Collins 2007). Sixteen trained endurance 
athletes ran 5 x 1000 m time trials after ingesting either sodium bicarbonate 
(NaHCO3) or a placebo in combination with being told correctly or deceived 
regarding what treatment had been administered (i.e. told NaHCO3/placebo, 
given/not given NaHCO3/placebo). The told NaHCO3/given placebo 
treatment performed the time trial significantly faster (-3.4 s / -1.8 %) than the 
told placebo/given NaHCO3 treatment demonstrating the effects of 
expectancy on exercise performance were greater than the purely 
pharmacological effects of NaHCO3. 
 
As there has been limited research on the potential psychobiological 
impact of NaHCO3 administration on exercise performance (McClung and 
Collins 2007) and based on previous data that suggests GI distress does not 
necessarily negatively influence exercise performance (Higgins et al. 2013; 
Price and Simons 2010) we speculated that replicating side effects of 
NaHCO3 ingestion might initiate a degree of expectancy of ergogenicity 
which might influence exercise performance.  Therefore, the aim of this study 
was to evaluate the effect of expectancy associated with NaHCO3 ingestion 
on high intensity cycling capacity. We hypothesised that by increasing the 
expectancy of ergogenicity a relatively inert compound (NaCl) mimicked as 
closely as possible and described as NaHCO3 would induce a significant 
increase in cycling capacity.  
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Materials and methods 
 
Participants 
 
Eight healthy and active male participants volunteered to take part in 
this study (age: 21±1 years, body mass: 75±8 kg, height: 178±4 cm) which 
received university ethics committee approval. All participants were 
recreationally active although not specifically cycle trained (WPEAK: 204±23 
W). In order to maximise the integrity of the treatment deception all 
participants were pre-screened to ensure they had not used alkalotic buffers 
for a minimum of 3 months. Furthermore, no participants had ever previously 
consumed NaHCO3 and only one had ever heard of its use with respect of 
sport and exercise performance. 
 
Pre-experimental procedures 
 
Participants were requested to avoid alcohol and strenuous exercise 
12 and 24 hours prior to exercise, respectively. Participants were also 
requested to adopt the same balanced diet for 24 hours prior to each trial 
with adherence monitored via self-reported food diaries. Participants were 
specifically requested to avoid low carbohydrate intake which can induce 
mild metabolic acidosis and subsequently negatively affect exercise capacity 
(Greenhaff et al. 1988). The aforementioned information was included in the 
participant information sheet (PIS) and confirmed verbally before written 
consent was provided. Each participant completed physical activity readiness 
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(PAR-Q) and blood screening questionnaires prior to the commencement of 
the study. Specifically, the blood screening questionnaire asked participants 
to report any serious infections, jaundice, haemophilia or anything that might 
be hazardous to the health of the participant or researcher. Individuals were 
only permitted to participate if they were deemed healthy and able to do so. 
Participants attended the laboratory at the same time of the day for each visit 
to minimise the influence of circadian changes on exercise performance 
(Fernandes et al. 2014). Trials were carried out 3 to 7 days apart. 
 
Protocol 
 
On the first visit to the laboratory, participants performed a graded 
incremental test to assess peak power output (WPEAK) on a cycle ergometer 
(Ergomedic 884E 1 – Sprint Cycle, Monark, Sweden). Participants selected 
the seat and pedal strap positions that felt most comfortable with these 
settings being adopted for all subsequent trials. After 5 min seated rest a 
finger prick capillary blood sample was taken and analysed for blood lactate 
concentration ([BLa]) (Biosen C_line, EKF Diagnostic, Magdeburg, 
Germany). All participants’ blood samples were analysed within ~ 10 minutes 
of the participant leaving the laboratory. 
 
Cycling commenced on the unloaded ergometer (70 W) at a cadence 
of 70 rev.min-1 with an increase of 35 W every 3 minutes until volitional 
exhaustion. Further blood samples were taken at the end of exercise and 5 
min post-exercise. Exhaustion was assumed via voluntary stoppage or the 
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cadence dropping below 70 rev.min-1 for longer than 5 seconds. Peak power 
output (WPEAK) was calculated as the mean power achieved during the final 
minute of the test (Lamberts et al. 2012). If exhaustion occurred less than 
one minute into a stage the appropriate duration undertaken at each power 
output was used to calculate a pro-rata WPEAK (Higgins et al. 2013).  
 
The second trial was a TLIM familiarisation at 100% WPEAK. After 5 min 
seated rest ratings of gut fullness (GF) and abdominal discomfort (AD) were 
recorded against an 11 point (0 to 10) scale with 0 representing ‘empty’ and 
‘completely comfortable’, respectively and 10 representing ‘bloated’ and 
‘unbearable pain’, respectively (Higgins et al. 2013). A fingerpick capillary 
blood sample was then taken and analysed for [BLa] and blood glucose 
concentration [BG] (Biosen C_line, EKF Diagnostic, Magdeburg, Germany). 
Participants then ingested a control solution consisting of 1 ml.kg-1 double 
strength no added sugar orange squash with sweeteners (Cooperative 
Group, Manchester, UK) mixed with 4 ml.kg-1 tap water in the first 5 min of a 
60 min seated rest period with GF and AD recorded at the end of this 5 min 
period. Prior to commencing exercise (i.e. at end of 60 min rest), heart rate 
(HR; F1 Polar Heart Rate Monitor, Polar, Finland), GF and AD were 
recorded. Participants then warmed up for 3 minutes on the unloaded 
ergometer (70 W) at a cadence of 70 rev.min-1. After a brief rest (~ 60 sec) 
participants commenced exercise from a stationary start position and were 
counted down from 5 seconds (Wittekind et al. 2011). Exhaustion was 
assumed as previously described. Measures of AD and GF were recorded 
again at the end of exercise and 5 min post-exercise. Heart rate, ratings of 
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perceived exertion specific to cardiovascular strain (RPEO) and specific to 
the leg musculature (RPEL) were recorded at 1 min intervals during exercise 
and at the end of exercise. The 15 point (6-20 category-ratio scale (CR-15) 
was used to assess RPEO which is deemed to have a linear relationship with 
work load, oxygen consumption and heart rate (Borg 1982). In contrast, the 
10 point (1-10) category-ratio scale (CR-10) was used to assess RPEL. This 
approach has been shown to correlate better with sensations associated with 
lactate accumulation (McClung and Collins 2007). Further blood samples for 
[BLa] and [BG] were taken at the end of exercise and 5 min post-exercise. 
After final measurements had been collected and after completing a self-
selected warm down participants left the laboratory. 
 
On the third and fourth visits to the laboratory participants completed 
experimental trials which were identical to the aforementioned exercise 
protocol with the following amendments. Prior to treatment ingestion 
participants were provided with a written manuscript which detailed the 
proposed effects of the subsequent treatment. For PLA the manuscript 
suggested that NaCl was relatively inert and would have little impact on 
exercise performance, whereas for SHAM the ‘proven’ ergogenicity of 
NaHCO3 was presented and in line with the AD and GF scales adopted the 
potential for associated feelings of GI distress such as build of gas and 
bloating were outlined. Participants then ingested either 0.1 g.kg-1 sodium 
chloride (NaCl) mixed with orange squash as previously described and either 
4 ml.kg-1 tap water (placebo; PLA), or 4 ml.kg-1 carbonated water (SHAM 
placebo; SHAM). Carbonated water was used for SHAM to differentiate from 
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PLA and to attempt to induce mild GI symptoms often associated with 
NaHCO3 ingestion such as gas/bloating. Control solutions demonstrated that 
the osmolality of PLA and SHAM were almost identical (510 ± 0 mOsmol/kg-1 
and 512 ± 10 mOsmol/kg-1, respectively). Solutions were prepared by a 
technician not involved in data collection and both treatments and 
manuscripts were administered double blind. Trials were counterbalanced to 
minimise any potential order effects.  
 
Statistical analysis 
 
Statistical analysis was completed using SPSS (IBM v21, Chicago, 
USA). For all data normality (Shapiro-Wilk) and homogeneity of 
variance/sphericity (Mauchly) were checked prior to choosing the appropriate 
statistical tests. For 2-way repeated measures ANOVAs ([BLa], [BG]) 
Bonferroni corrections were applied. In some instances an ANOVA was 
chosen despite the majority of data not being normally distributed (i.e. AD 
and GF). This was decided so as to minimise the potential for type-I error 
due to multiple individual (non-parametric) comparisons and because of the 
general robustness of the univariate ANOVA test to violations of normality 
(Schmider et al. 2010). Additionally although RPEO, RPEL and HR were 
collected
 
during each minute of TLIM, due to the variation in performance and 
small samples sizes at some time points analysis has only been completed 
between treatments for 1 to 7 minutes and at the end of exercise where at 
least 50% of data points were available for both treatments (minimum of n=4 
comparison). With the exception of after 4 min TLIM, where a Mann-Whitney 
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U test was used (for unequal sample size comparisons), RPEO, RPEL and HR 
were analysed by paired t-tests or Wilcoxon tests. Exercise capacity (TLIM) 
was analysed using a paired t-test. 
 
Data were analysed and quantified using a mixture of effect sizes 
(ES), P values (minimum P ≤ 0.05) and, where appropriate, 95% confidence 
intervals (Watt et al. 2002). Unless otherwise stated data is presented as 
mean ± standard deviation. For ANOVA main effects and interactions the ES 
is reported as the partial η2 value. Otherwise, for normally distributed data the 
ES (d) was calculated using the difference in means divided by the pooled 
SD of the compared trials (Nakagawa and Cuthill 2007).  
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Results 
 
Exercise capacity 
 
Mean TLIM increased by 9.5% (40±47 s; 95%CI: 0.4 to 80 s) for SHAM 
vs. PLA (461±148 s vs. 421±150 s; P=0.048, d=0.3; Figure 1). No order 
effect was found between trials (448±130 s vs. 435±168 s; P=0.574, d=0.1). 
 
****Figure 1 near here**** 
 
Perceptual variables 
 
There was no time and treatment interaction for GF (P=0.276, η2=0.2). 
Although GF increased by ~ 1 unit at all time points post SHAM ingestion 
compared with PLA ingestion only a tendency towards a main effect for 
treatment was observed (P=0.080; η2=0.4). In contrast, there was a main 
effect for time (P<0.001; η2=0.7). More specifically, GF post-ingestion 
(1.7±1.1) was greater than rest (0.0±0.0; P=0.002; d=2.1), end of exercise 
(0.4±1.1, P=0.031; d=1.2) and 5 min post-exercise (0.3±0.9, P=0.012; 
d=1.4). Pre-exercise, GF (0.7±0.9) was also greater than 5 min post-exercise 
(P=0.025; d=0.4; Figure 2). There was no time and treatment interaction for 
AD (P=0.451, η2=0.1). Similar to GF, although AD increased by ~ 1 unit at all 
time points post SHAM ingestion compared with PLA ingestion, only a 
tendency towards a main effect for treatment was observed (P=0.096; 
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η
2
=0.3). Unlike GF there was no main effect for time for AD (P=0.299, 
η
2
=0.2).  
 
****Figure 2 near here**** 
 
After 3 min TLIM RPEO was 1.4±1.3 units lower for SHAM (12.9±2.5) 
units compared to PLA (14.3±2.5; P=0.020, d=0.6).  Although none of the 
other comparisons between treatments were significantly different, RPEO 
was also lower for SHAM vs. PLA after 2, 5, 6 and 7 min and at the end of 
exercise (Figure 3). There were no differences between treatments for RPEL 
although values were lower for SHAM vs. PLA after 3, 5, 6 and 7 min and at 
the end of exercise. 
 
****Figure 3 near here**** 
 
Blood and cardiorespiratory variables 
 
There was no time and treatment interaction (P=0.149, η2=0.2) or 
main effect for treatment for [BLa] (P=0.552, η2=0.1). However, there was a 
main effect for time (P<0.001, η2=0.9). At the end of exercise 8.91±1.70 
mmol.l-1) and 5 min post-exercise (6.57±1.10 mmol.l-1) [BLa] was greater 
than at rest (1.27±0.20 mmol.l-1; both P<0.001 and d>6). Additionally, [BLa] 
was lower 5 min post-exercise compared to the end of exercise (P=0.004, 
d=1.6). There was no time and treatment interaction (P=0.210, η2=0.2) or 
main effect for treatment for [BG] (P=0.629, η2<0.1). However, there was a 
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main effect for time (P<0.001, η2=0.9). At the end of exercise (3.68±0.22 
mmol.l-1) and 5 min post-exercise (3.54±0.26 mmol.l-1) [BG] was lower than 
at rest (4.64±0.40 mmol.l-1; both P≤0.001; d>3). There was no difference 
between treatments for HR although HR increased linearly over time. At the 
end of exercise HR for SHAM (174±9 bpm-1) and PLA (173±13 bpm-1) was 
greater than at rest (77±9 bpm-1 and 79±7 bpm-1, respectively, both P<0.001, 
d>9). 
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Discussion 
 
This study evaluated the effect of providing pre-exercise information 
designed to increase expectancy associated with NaHCO3 ingestion on high 
intensity cycling capacity in recreationally active males. In support of our 
original hypothesis mean TLIM for SHAM was 9.5% longer (40 s) than PLA. In 
terms of contextualising the magnitude of this change, this is considered a 
moderate improvement. More simply the effect size of 0.3 sits between the 
0.2 (small) and 0.5 (medium) benchmarks as originally suggested by Cohen 
(1988).  Interestingly, this magnitude of improvement is in line with the range 
of effect sizes (mean: 0.69; 95%CI: -0.07-1.63) for untrained individuals who 
have actually ingested NaHCO3 prior to exercise using a time to volitional 
fatigue (TLIM) protocol (Peart et al. 2012).  
 
Beedie et al. (2007) suggest that placebo effects in sports 
performance are likely when individuals believe that they have ingested an 
ergogenic substance. Similar to McClung and Collins (2007), manipulative 
scripts were used in the present study to influence participant perception as 
to what they would be ingesting. Additionally, SHAM was mixed with 
carbonated water to try and replicate the reported side effects of NaHCO3 
ingestion. Although symptoms were mild, in the present study gut fullness 
increased by ~ 1 unit for all trials post SHAM ingestion compared with PLA 
suggesting this strategy might have contributed to any increase in 
expectancy experienced by participants. It is important to highlight that we 
purposefully chose to not replicate the experimental design as adopted by 
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McClung and Collins (2007). Due to the well acknowledged variety and 
sometimes severe GI responses (Cameron et al. 2010; Carr et al. 2011) it 
was felt that actually administering NaHCO3 to participants could render the 
SHAM treatment ineffective in enhancing expectancy due to participants 
associating more severe GI symptoms with ‘genuine’ NaHCO3 ingestion 
(Cameron et al. 2010). As such by comparing only PLA and SHAM, whose 
only differences were the information given pre-exercise and whether the 
water was tap or carbonated, we have been able to isolate the effects of pre-
exercise information designed to increased expectancy of ergogenicity with 
NaHCO3 ingestion on exercise capacity. It appears that this strategy has 
contributed to the observed increase in exercise capacity, at least in some 
individuals. 
 
Compared with PLA RPEO was 1.4±1.3 units lower for SHAM after 3 
min TLIM with the associated effect size (0.6) equivalent to a medium to large 
magnitude of change (Cohen 1988). Moreover, both RPEO and RPEL were 
generally lower for SHAM versus PLA throughout TLIM. These results suggest 
that the information given to participants prior to exercise might have led to 
reduced perception of effort during exercise for SHAM which is likely to have 
contributed to the increase in TLIM. Our results are supported by McClung 
and Collins (2007) who reported that RPE (based on perceptions of lactate 
accumulation and therefore most similar to RPEL in the present study) was 
1.5 units lower for the told NaHCO3/given placebo trial compared to the told 
placebo/given placebo trial with the told NaHCO3/given placebo trial 
performing the 1 km time trial -2.8 s / -1.5% faster. Interestingly, both results 
Page 16 of 31
17 
 
 
 
are similar to Higgins et al. (2013) who reported RPEL was 1.5 units lower 
after both 1 and 2 min of TLIM cycling at 100% WPEAK after NaHCO3 ingestion. 
Moreover, the authors reported significant correlations between TLIM and 
RPEL at the same time points. Therefore, it is plausible that reductions in 
RPE and any impact on exercise performance are not solely due to NaHCO3 
induced mediation of acid-base balance (i.e. the pharmacological effects). 
These results are in accordance with the psychobiological model which 
suggests that reduced perception of effort can increase exercise 
performance (Ross et al. 2015; Smirmaul, et al. 2013) with perception of 
effort postulated as a key determinant of exercise tolerance (Marcora and 
Staiano 2010). The reduction in perception of effort might be linked to the 
mediation of endogenous opioids via expectancy orientated placebo effects 
(Benedetti et al. 2005).   
 
In the present study the mean 9.5% (+40 s) increase in exercise 
capacity after SHAM is substantially larger than the -1.5 % (-2.8 s) 
improvement for the placebo/told NaHCO3 trial compared with the given 
placebo/told placebo trial reported by McClung and Collins (2007). This is 
likely due to a number of methodological differences between studies such 
as exercise protocol (capacity test vs. time trial), exercise modality (cycling 
ergometry vs. track running), participant training status (recreationally active 
vs. trained), placebo dosage (0.1 g.kg-1 vs. “pinch” of NaCl), volume (5 ml.kg-
1
 vs. standardised 750 ml) and choice of solvent (carbonated water vs. 
(presumably) tap water) used to mix experimental solutions. However, it 
seems clear from both studies that deceptive information given pre-exercise 
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with regards to NaHCO3 ingestion has subsequently improved performance 
when compared with placebo. 
 
Despite the expected increases in [BLa] and HR and decreases in 
[BG] from rest to post-exercise, respectively, in the present study there were 
no interactions or main effects for treatment for any of the cardiorespiratory 
or haematological data collected. The lack of difference between treatments 
for [BLa] after exercise in the present study (SHAM: 8.84 ± 1.72 mmol.l-1, 
PLA: 8.99 ± 1.79 mmol.l-1) is in accordance with McClung and Collins (2007).  
Taken together, these data suggest that these physiological variables did not 
contribute to the observed differences in TLIM. 
 
To the best of our knowledge the daily variation for TLIM at 100% 
WPEAK in recreationally active participants is currently unknown. Therefore, 
we have compared participant’s individual data to the daily variation of ~ 
11% / 24 s reported for participants of a similar training status who engaged 
in two bouts of TLIM cycling at 110% WPEAK (Higgins et al. 2014). In the 
present study five of the eight participants increased TLIM for SHAM above 
daily variation (range: 12% to 32%; 53 to 104 s) with two participants 
showing no difference (range: -2% to 3%; -10 to 14 s) with only one 
recording lower TLIM for SHAM (-9%; -39s). It is unclear why expectancy 
appears to have influenced some but not all individuals but it is plausible that 
individuals might respond differently to expectancy at different exercise 
intensities.  
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It is important to acknowledge that there are some limitations to our study. 
Firstly, the present study examined the effects of expectancy related to an 
oral bolus solution ingested 60 min prior to exercise. This method was 
chosen because NaHCO3 based solutions are widely used in contemporary 
research (Higgins et al. 2013; McClung and Collins 2007; Price and Simons 
2010). In contrast NaHCO3 is also often administered via capsules and/or 
ingestion is staggered over multiple dosages (Carr et al. 2011; Krustrup et al. 
2015). Further research is warranted to examine whether these ingestion 
methods report results similar to the present study. Secondly, although 
limited anecdotal evidence was recorded (e.g. participant one left the lab 
stating “that stuff definitely works!”; analysis after the study revealed this was 
for a SHAM trial which translated into a 65 s / 13% increase compared with 
PLA) we did not carry out post-hoc qualitative analysis which could have 
provided important information to verbally confirm the presence or not of 
expectancy at an individual level. Finally, as the placebo effect is a 
psychobiological phenomenon that is linked to different mechanisms 
including Pavlovian conditioning and expectation of improvement, it is 
important to acknowledge that there is no singular placebo effect. As such, 
different mechanisms might be responsible in different conditions (Benedetti 
et al. 2005). That said, according to McClung and Collins (2007) the vast 
majority of placebo effects are due to expectancy and in the context of our 
study design it seems likely expectancy has played at least some role in 
facilitating improvements in TLIM. 
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From a practical application perspective, the results from this study 
suggest that athletes and coaches should consider psychobiological 
strategies which could positively impact physical training and/or performance 
to a similar extent as reported pharmacological agents. This might be 
especially important for individuals who have empirical evidence that 
NaHCO3 induced GI distress negatively impacts their performance. Indeed, 
the development of psychological skills can be as important as physiological 
adaptations when looking to improve sport and exercise performance 
(Beedie and Foad 2009).  
 
In conclusion, providing pre-exercise information designed to increase 
expectancy associated with NaHCO3 ingestion, administered via an oral 
bolus solution, improved mean cycling capacity at 100% WPEAK by ~ 10%.  In 
conjunction with the psychobiological model of exercise performance the 
increase in exercise capacity was likely facilitated by reduced perception of 
overall effort, possibly due to mediation of endogenous opioids via 
expectancy orientated placebo effects. The observed ergogenicity with 
SHAM did not affect our measures of cardiorespiratory physiology or 
metabolic flux. 
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Figure Legends 
 
Figure 1 – Individual time until volitional exhaustion (TLIM; s) at 100% WPEAK 
for SHAM vs. PLA. SHAM > PLA (P=0.048, d=0.3). 
 
Figure 2 – Perceptual ratings of gut fullness (GF) over time for SHAM vs. 
PLA. Error bars represent 1 SD (a=SHAM, b=PLA). * Post-ingestion > Rest 
(P=0.002), # Post-ingestion > end of exercise (P=0.031), $ Post-ingestion > 5 
min post-exercise (P=0.012), ** Pre-exercise > 5 min post-exercise 
(P=0.025). 
 
Figure 3 – Ratings of perceived exertion representative of cardiovascular 
strain (RPEO) over time for SHAM vs. PLA. Error bars represent 1 SD. * 
SHAM < PLA (P=0.020).  
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